INS and cancer: Metformin, a biguanide derivative primarily used to lower blood glucose in T2DM, acts by reducing hepatic gluconeogenesis, improving insulin sensitivity, and enhancing peripheral glucose uptake [76]. The concept of repurposing metformin as an anti-cancer drug has gained traction in the last 15 years.